Infect Immun. 1993 October; 61(10): 4072-4078
Virulence of Bordetella bronchiseptica: role of adenylate cyclase-hemolysin.
P Gueirard and
N Guiso
Unité de Bactériologie Moléculaire et Médicale, Institut Pasteur, Paris, France.
ABSTRACT
Bordetella bronchiseptica is a pathogen of laboratory, domestic, and wild animals and sometimes of humans. In the present study some characteristics of the virulence of B. bronchiseptica isolates of different origin were studied. All isolates had similar phenotypes, similar bacteriological characters, and synthesized adenylate cyclase-hemolysin, filamentous hemagglutinin and pertactin but not pertussis toxin. These isolates, however, differed in their ability to express dermonecrotic toxin and to cause a lethal infection, but no correlation was found with the human or animal origin of the isolates. The fact that the most virulent isolate did not express dermonecrotic toxin suggests that this toxin does not play an important role in the virulence of the bacteria in the murine model. After infection with virulent B. bronchiseptica a very early synthesis and a persistence of anti-adenylate cyclase-hemolysin and anti-filamentous hemagglutinin antibodies were observed in the sera of infected mice, suggesting a persistence of the bacteria or of its antigens. B. bronchiseptica adenylate cyclase-hemolysin was purified and was shown to be a major protective antigen against B. bronchiseptica infection. Furthermore, we showed that its immunological and protective properties were different from that of B. pertussis adenylate cyclase-hemolysin, confirming that Bordetella species are immunologically different.
Infect Immun. 1993 October; 61(10): 4072-4078
This article has been cited by other articles:
-
Stenson, T. H., Allen, A. G., al-Meer, J. A., Maskell, D., Peppler, M. S.
(2005). Bordetella pertussis risA, but Not risS, Is Required for Maximal Expression of Bvg-Repressed Genes. Infect. Immun.
73: 5995-6004
[Abstract]
[Full Text]
-
Mattoo, S., Cherry, J. D.
(2005). Molecular Pathogenesis, Epidemiology, and Clinical Manifestations of Respiratory Infections Due to Bordetella pertussis and Other Bordetella Subspecies. Clin. Microbiol. Rev.
18: 326-382
[Abstract]
[Full Text]
-
Gueirard, P., Ave, P., Balazuc, A.-M., Thiberge, S., Huerre, M., Milon, G., Guiso, N.
(2003). Bordetella bronchiseptica Persists in the Nasal Cavities of Mice and Triggers Early Delivery of Dendritic Cells in the Lymph Nodes Draining the Lower and Upper Respiratory Tract. Infect. Immun.
71: 4137-4143
[Abstract]
[Full Text]
-
Sisti, F., Fernandez, J., Rodriguez, M. E., Lagares, A., Guiso, N., Hozbor, D. F.
(2002). In Vitro and In Vivo Characterization of a Bordetella bronchiseptica Mutant Strain with a Deep Rough Lipopolysaccharide Structure. Infect. Immun.
70: 1791-1798
[Abstract]
[Full Text]
-
Brockmeier, S. L., Register, K. B., Magyar, T., Lax, A. J., Pullinger, G. D., Kunkle, R. A.
(2002). Role of the Dermonecrotic Toxin of Bordetella bronchiseptica in the Pathogenesis of Respiratory Disease in Swine. Infect. Immun.
70: 481-490
[Abstract]
[Full Text]
-
Schneider, B., Gross, R., Haas, A.
(2000). Phagosome Acidification Has Opposite Effects on Intracellular Survival of Bordetella pertussis and B. bronchiseptica. Infect. Immun.
68: 7039-7048
[Abstract]
[Full Text]
-
Jungnitz, H., West, N. P., Walker, M. J., Chhatwal, G. S., Guzman, C. A.
(1998). A Second Two-Component Regulatory System of Bordetella bronchiseptica Required for Bacterial Resistance to Oxidative Stress, Production of Acid Phosphatase, and In Vivo Persistence. Infect. Immun.
66: 4640-4650
[Abstract]
[Full Text]
Copyright © 1993 by the American Society for Microbiology. All rights reserved.